Life ScienceCompany
EpiBiome - Bacteriophage Platform Ownership
Who owns EpiBiome - Bacteriophage Platform?
EpiBiome - Bacteriophage Platform is owned by Locus Biosciences. It was acquired on July 17, 2018.
EpiBiome - Bacteriophage Platform Business Overview
Where is EpiBiome - Bacteriophage Platform headquartered?
EpiBiome - Bacteriophage Platform is headquartered in San Francisco, California.
What sector is EpiBiome - Bacteriophage Platform in?
EpiBiome - Bacteriophage Platform is a life science company.
Life Science M&A Summary in 2018
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.
Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.